Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Department of Surgery, Germany.
Technical University of Munich, School of Medicine, Klinikum rechts der Isar, Department of Surgery, Germany.
Pancreatology. 2018 Apr;18(3):334-345. doi: 10.1016/j.pan.2018.02.013. Epub 2018 Feb 23.
Although routinely used, the benefit of surgically placed intraperitoneal drains after pancreas resection is still under debate. To assess the true impact of intraperitoneal drains in pancreas resection, a systematic review with meta-analysis was performed.
For this, the Preferred-Reporting-Items-for-Systematic-review-and-Meta-Analysis/PRISMA-guidelines were conducted and Pubmed/Medline, Embase, Scopus and The Cochrane Library were screened for relevant studies.
8 retrospective and 3 prospective studies were included in the systematic review. No difference was found between patients with or without intraperitoneal drains in mortality (Risk-ratio/RR 0.74, 95%-Confidence-interval/CI: 0.47-1.18, p = 0.20), in Grade B/C-postoperative pancreatic fistulas/POPF (RR 1.31, 95%-CI: 0.74-2.32, p = 0.35), in intraabdominal abscesses (RR 0.92, 95%-CI: 0.65-1.30, p = 0.64), in surgical site infection (RR 1.20, 95%-CI: 0.85-1.70, p = 0.30), in delayed gastric emptying (RR 1.11, 95%-CI: 0.65-1.90, p = 0.71), in postoperative haemorrhages (RR 0.92 95%-CI: 0.63-1.33, p = 0.65), in reoperations (RR 1.15, 95%-CI: 0.87-1.52, p = 0.33), or in radiological reinterventions (RR 0.95, 95%-CI: 0.69-1.31, p = 0.76). The risk for overall morbidity (RR 1.16, 95%-CI: 1.04-1.29, p = 0.008), of any POPF (RR 2.15, 95%-CI: 1.52-3.04, p < 0.0001) and of readmissions (RR 1.23, 95%-CI: 1.04-1.45, p = 0.01) was increased for patients with intraperitoneal drain compared to patients without following pancreatic resection.
Regarding the controversial results of the recent prospective, randomized trials this meta-analysis revealed no difference in mortality but an increased risk for postoperative morbidity, POPF and readmissions of patients with intraperitoneal drains after pancreatic resection. Therefore, the indication for intraperitoneal drains should be critically weighed in patients undergoing pancreatic resections.
尽管常规应用,但胰腺切除术后放置腹腔引流管的益处仍存在争议。为了评估腹腔引流管在胰腺切除术中的真实影响,我们进行了系统评价和荟萃分析。
为此,我们遵循了首选报告项目的系统评价和荟萃分析/PRISMA 指南,并对 Pubmed/Medline、Embase、Scopus 和 The Cochrane Library 进行了筛选,以寻找相关研究。
系统评价共纳入 8 项回顾性研究和 3 项前瞻性研究。在死亡率方面,有或没有腹腔引流管的患者之间没有差异(风险比 RR 0.74,95%置信区间 CI:0.47-1.18,p=0.20),在术后 B/C 级胰瘘/ POPF(RR 1.31,95%置信区间 CI:0.74-2.32,p=0.35)、腹腔脓肿(RR 0.92,95%置信区间 CI:0.65-1.30,p=0.64)、手术部位感染(RR 1.20,95%置信区间 CI:0.85-1.70,p=0.30)、胃排空延迟(RR 1.11,95%置信区间 CI:0.65-1.90,p=0.71)、术后出血(RR 0.92 95%置信区间 CI:0.63-1.33,p=0.65)、再次手术(RR 1.15,95%置信区间 CI:0.87-1.52,p=0.33)或影像学再介入(RR 0.95,95%置信区间 CI:0.69-1.31,p=0.76)方面。与无腹腔引流管的患者相比,接受胰腺切除术后,腹腔引流管患者的总并发症风险(RR 1.16,95%置信区间 CI:1.04-1.29,p=0.008)、任何 POPF(RR 2.15,95%置信区间 CI:1.52-3.04,p<0.0001)和再入院(RR 1.23,95%置信区间 CI:1.04-1.45,p=0.01)的风险增加。
鉴于最近前瞻性、随机试验的争议结果,本荟萃分析显示,胰腺切除术后放置腹腔引流管在死亡率方面没有差异,但增加了术后发病率、POPF 和再入院的风险。因此,在接受胰腺切除术的患者中,应慎重考虑腹腔引流管的适应证。